4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 23, 2023 15:30 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 17, 2023 14:51 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 7, 2023 15:17 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 3, 2023 12:09 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 18, 2022 14:58 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 15, 2022 13:53 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oct 7, 2022 10:58 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Sep 30, 2022 15:04 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Aug 24, 2022 17:06 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Aug 24, 2022 16:56 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Aug 24, 2022 16:43 ET
4D pharma | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Jul 19, 2022 11:48 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jul 5, 2022 14:06 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 29, 2022 14:25 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 24, 2022 17:19 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 24, 2022 09:19 ET
4D pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Jun 1, 2022 15:31 ET
4D pharma | EFFECT: Others
Apr 29, 2022 00:15 ET
4D pharma | CORRESP: CORRESP
Apr 26, 2022 17:47 ET
4D pharma | UPLOAD: Others
Apr 26, 2022 11:30 ET
No Data
No Data